DirectDetect qPCR Test Kit

Real time reverse transcription PCR assay for the qualitative detection of Covid-19

qPCR Kit Overview

This PCR assay is produced by Coyote Biosciences.

This product features:

  • Manual handling time less than 1 minute 
  • Sample to result time 1-1.5 hrs 
  • Very simple operation 
  • Sensitivity: 97.98% 
  • Specificity: 95.77%

Coyote’s DirectDetect Method platform have international PCT patents applied worldwide, and was granted in US, Australia, and soon in Europe and many other countries. It breaks through the speed limit of nucleic acids reactions by parallel thermal cycling and the sample to answer time is less than 1 hour. This method can be applied in both centralized labs for high throughput testing (1000tests/ day), and decentralized clinics for point of care applications (100 tests/ site).

DirectDetectTM SARS-CoV-2 QPCR Kit is an in vitro diagnostic real time reverse transcription PCR assay for the qualitative detection of SARS-CoV-2 nucleic acids in throat swabs from individuals suspected of COVID 19 by their healthcare provider, which is completed the laboratory and clinical case verification. 

The SARS-CoV-2 RNA is generally detectable in throat swabs during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; Results are for the identification of SARS-CoV-2 RNA. Clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. 

DirectDetectTM SARS-CoV-2 QPCR Kit is intended for use by trained clinical laboratory personnel specifically instructed and trained in the techniques of Realtime PCR and in vitro diagnostic procedures.

About Coyote Bioscience